Successful Outcome of Disseminated Fusarium musae Fungemia with Skin Localization Treated with Liposomal Amphotericin B and Voriconazole in a Patient with Acute Myeloid Leukemia.
Amphotericin B
Fungemia
Fusarium spp.
Leukemia
Voriconazole
Journal
Mycopathologia
ISSN: 1573-0832
Titre abrégé: Mycopathologia
Pays: Netherlands
ID NLM: 7505689
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
22
07
2020
accepted:
08
10
2020
pubmed:
30
10
2020
medline:
4
9
2021
entrez:
29
10
2020
Statut:
ppublish
Résumé
Fusarium spp. may cause invasive disseminated infections in immunocompromised patients, associated with significant morbidity and mortality. We describe a case of disseminated fusariosis with fungemia and skin localization caused by Fusarium musae in a patient with acute myeloid leukemia successfully treated using liposomal amphotericin B and voriconazole.
Identifiants
pubmed: 33119817
doi: 10.1007/s11046-020-00499-w
pii: 10.1007/s11046-020-00499-w
doi:
Substances chimiques
Antifungal Agents
0
liposomal amphotericin B
0
Amphotericin B
7XU7A7DROE
Voriconazole
JFU09I87TR
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1085-1089Références
Normand AC, Becker P, Gabriel F, Cassagne C, Accoceberry I, Gari-Toussaint M, Hasseine L, De Geyter D, Pierard D, Surmont I, Djenad F, Donnadieu JL, Piarroux M, Ranque S, Hendrickx M, Piarroux R. Validation of a new web application for identification of fungi by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2017;55:2661–70.
doi: 10.1128/JCM.00263-17
EUCAST. Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds—subcommittee on antifungal susceptibility testing (AFST) of the ESCMID European committee for antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2008;14:982–4.
doi: 10.1111/j.1469-0691.2008.02086.x
Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695–704.
doi: 10.1128/CMR.00014-07
Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect. 2004;10:67–75.
doi: 10.1111/j.1470-9465.2004.00845.x
Fanci R, Pini G, Bartolesi AM, Pecile P. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Rev Iberoam Micol. 2013;30:51–3.
doi: 10.1016/j.riam.2012.05.003
Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol. 2012;50:1051–3.
doi: 10.1128/JCM.05946-11
Tezcan G, Ozhak-Baysan B, Alastruey-Izquierdo A, et al. Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. J Clin Microbiol. 2009;47:278–81.
doi: 10.1128/JCM.01670-08
Bhatti Z, Shaukat A, Almyroudis NG, Segal BH. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients. Mycopathologia. 2006;162:1–15.
doi: 10.1007/s11046-006-0025-x
Espinel-Ingroff A, Colombo AL, Cordoba S, et al. International evaluation of mic distributions and epidemiological cutoff value (ecv) definitions for fusarium species identified by molecular methods for the clsi broth microdilution method. Antimicrob Agents Chemother. 2016;60:1079–84.
doi: 10.1128/AAC.02456-15
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston KV, Strasfeld L, Flowers CR. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol. 2018;36:3043.
doi: 10.1200/JCO.18.00374
Stanzani M, Vianelli N, Bandini G, et al. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect. 2006;53:E243–6.
doi: 10.1016/j.jinf.2006.02.011
Rojas R, Molina JR, Jarque I, et al. Outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination. Mediterr J Hematol Infect Dis. 2012;4:e2012011.
doi: 10.4084/mjhid.2012.011
Nucci M, Marr KA, Vehreschild MJGT, et al. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect. 2014;20:580–5.
doi: 10.1111/1469-0691.12409